Latest news
Vertex Tops Q2 Estimates, But Investors Shift Focus to Crinetics Deal Integration - NAI500NAI500 · Wed, 05 Aug 2026 01:42:37 GMTCrinetics Pharmaceuticals (CRNX) On Vertex Deal Optimism And Results Looks Nearly Fully Valued - finance.yahoo.comfinance.yahoo.com · Tue, 04 Aug 2026 21:11:40 GMTCrinetics Q2 Revenue Rises to $25.1 Million Ahead of Vertex Deal - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 20:22:00 GMTCrinetics' once-daily acromegaly treatment brought in $24M in Q2 - Stock TitanStock Titan · Mon, 03 Aug 2026 20:05:00 GMTAbCellera Biologics (ABCL) Signs Vertex Deal, Is The Stock Still Cheap? - simplywall.stsimplywall.st · Sat, 01 Aug 2026 07:00:00 GMTVertex’s latest autoimmune TCE play involves $28M to AbCellera - Fierce BiotechFierce Biotech · Wed, 29 Jul 2026 12:20:42 GMTAbCellera expands multispecific T-cell engager licensing with USD 28m Vertex deal for autoimmune disease - AllSciAllSci · Wed, 29 Jul 2026 07:00:00 GMTAbCellera inks drug discovery deal with Vertex Pharma - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 07:00:00 GMT